ASSOCIATION BETWEEN SERUM METABOLOMIC PROFILES AND PSYCHONEUROLOGICAL SYMPTOMS IN WOMEN WITH EARLY-STAGE BREAST CANCER OVER ONE YEAR.

Background & Significance: Advances in early detection and treatment have substantially improved survival in breast cancer survivors (BCS). However, across the cancer treatment trajectory and into longterm survivorship, 40% to 90% of women report a clinically meaningful burden of psychoneurological...

Descripción completa

Detalles Bibliográficos
Publicado en:Oncology Nursing Forum Vol. 53; no. 2; pp. 32 - 34
Autores principales: Yang, Gee Su, Starkweather, Angela, Lin, Tuo, Hashemian, Tara, Garrett, Timothy, Lyon, Debra
Formato: Journal Article
Publicado: Oncology Nursing Society Mar2026
Acceso en línea:Ver este registro en EBSCOhost